Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
What can the QBSafe trial teach us about person-centered diabetes care? Explore its findings on A1C, medication adherence, and patient priorities.
Read More »Start With the Patient, Not the A1C: What Happens When Visits Ask “What Matters Most?”
The SGLT2 Hemoglobin Effect: A Clue to Cardiorenal Protection?
Learn how SGLT2 inhibitors affect hemoglobin and hematocrit, and what a JAMA meta-analysis reveals about possible heart and kidney benefits.
Read More »Can Better Self-Management Protect the Kidneys Before Damage Takes Hold?
Can better diabetes self-management protect kidney health? Explore new trial findings on A1C, blood pressure, cholesterol, and kidney function.
Read More »Metformin Before the ICU: A Surprising Kidney Signal Challenges the Usual Narrative
A new ICU study links prior metformin use to lower odds of acute kidney injury. Explore the findings, limitations, and implications for diabetes care.
Read More »High-Fiber Diet vs. Metformin: A Small Trial Delivers a Surprising Result
A small 84-day trial found greater A1C and BMI improvements with a high-fiber diet than metformin. Explore the results, limitations, and clinical implications.
Read More »Quit Smoking, Protect More Than Your Heart: When Diabetes Complication Risk Starts to Fall
New research links smoking cessation to lower diabetes complication risks. Explore what the findings mean for kidney, eye, and nerve health.
Read More »Why Are ADHD and Autism Showing Up More Often in Young People With Type 2 Diabetes?
New EASD research links neurodiversity and type 2 diabetes in younger people, highlighting ADHD, autism, and the need for tailored diabetes care.
Read More »Three Weeks of Treatment, Months of Better Glucose? A New Diabetes Drug Is Testing an Unusual Idea
Early Phase 1b data suggest balomenib may improve glucose control after treatment ends. Learn what the results could mean for type 2 diabetes.
Read More »The First Years After a Type 2 Diabetes Diagnosis May Matter More Than We Thought
Early hyperglycemia may influence cancer risk after type 2 diabetes diagnosis. See what a large cohort study found about early glycemic exposure.
Read More »Numbness Isn’t Always Diabetic Neuropathy: The Metformin-B12 Connection That’s Easy to Miss
Metformin B12 deficiency can cause numbness that resembles diabetic neuropathy. Learn who is at risk, when to test B12, and why early detection matters.
Read More »